Lilly Invests $6 Billion on New Alabama Drug Manufacturing Site
Eli Lilly is set to build a massive new $6 billion facility in Huntsville, Alabama, part of a growing U.S. push to bring medicine manufacturing back home. The site will make active pharmaceutical ingredients (APIs) for small-molecule synthetic and peptide medicines. That includes orforglipron, Lilly’s first weight-loss drug. What’s Related Construction kicks off in 2026 […]